Mukund S. Chorghade

Dr. Mukund Chorghade is the President of Chorghade Enterprises and Chief Scientific Officer, THINQ Pharma. He provides consultations to pharmaceutical researchers on collaborations with academic, government and industrial laboratories. He advises technology based companies on process re-engineering and project management of technology transfer; establishes strategic partnerships and conducts cGLP/cGMP compliance training and implementation in chemical laboratories. He oversees projects in medicinal chemistry, chemical route selection, process development, manufacturing and formulation of bulk actives to finished dosage forms.

Dr. Chorghade earned his B. Sc. and M. Sc. degrees from the University of Poona in India and a Ph. D. in organic chemistry at Georgetown University in Washington, D.C. He completed postdoctoral appointments at the University of Virginia and Harvard University, visiting scientist appointments at University of British Columbia, College de France / Universite' Louis Pasteur, Cambridge and Caltech and directed research groups at Dow Chemicals, Abbott Laboratories, CytoMed and Genzyme.

A recipient of three "Scientist of the Year Awards", he is an elected Fellow of the ACS, AAAS and RSC and has been a featured speaker in several national and international symposia. He is active in ACS, was NESACS and Brazosport Chair and serves on the International Activities Committee.